Liang, Jinsheng
Novartis Institutes for BioMedical Research
2 papers on CoChat
Most cited papers
- Verified
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Elkabets, M., Pazarentzos, E., Juric, D., Sheng, Q., Pelossof, R. A., Brook, S., Benzaken, A. O., Rodon, J., Morse, N., Yan, J. J., et al. (2015) · Cancer Cell
PI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and Mutations
Cited by 325
- Verified
Combined ALK and MDM2 inhibition increases antitumor activity and overcomes resistance in human ALK mutant neuroblastoma cell lines and xenograft models
Wang, H. Q., Halilovic, E., Li, X., Liang, J., Cao, Y., Rakiec, D. P., Ruddy, D. A., Jeay, S., Wuerthner, J. U., Timple, N., et al. (2017) · eLife
Neuroblastoma Research and TreatmentsLung Cancer Treatments and Mutations
Cited by 45
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free